4//SEC Filing
Rosol Michael Stanley 4
Accession 0001437749-21-029413
CIK 0000810509other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:56 PM ET
Size
5.1 KB
Accession
0001437749-21-029413
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2021-12-27$0.00/sh+100,000$100→ 100,000 totalExercise: $1.08Exp: 2031-12-27→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-fourth on each of the first four anniversaries of the date of grant.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:56 PM ET
- Size
- 5.1 KB